Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Neoadjuvant Chemo-hypoRT Plus PD-1 Antibody (Tislelizumab) in Resectable LA-G/GEJ [Phase 2]
This clinical trial update describes a Phase 2 study evaluating neoadjuvant chemotherapy and hypofractionated radiotherapy combined with the…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ [Phase 2]
Phase 2 clinical trial evaluating Adebrelimab in combination with chemoradiotherapy and surgery for gastroesophageal junction and gastric ad…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluating Novel Therapies in ctDNA Positive GI Cancers [Phase 3]
Georgetown University is conducting a Phase 3 trial evaluating novel therapies for ctDNA-positive gastrointestinal cancers, currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
A completed clinical trial evaluating PET imaging with the radiotracer 18F-BMS-986229 in patients with cancers of the esophagus, stomach, or…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) [Phase 2]
Phase 2 study evaluating IMU-131 (HER-Vaxx) with chemotherapy or pembrolizumab in metastatic HER2-overexpressing gastric cancer; the trial w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating total neoadjuvant FLOT chemotherapy for locally advanced gastric and gastroesophageal junction cancer;…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 2]
Phase 2 study evaluating a combination of QLS31905, QL2107, and chemotherapy as first-line therapy for CLDN18.2-positive unresectable locall…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating Tirellizumab combined with oral, IV, and intraperitoneal chemotherapy for gastric/gastroesophageal junction/esophag…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma [NA]
Clinical trial OPPOSITE, studying outcome prediction of systemic treatment in esophagogastric carcinoma, has completed. The sponsor is Unive…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers [Phase 1]
Phase 1 study of the oral STAT3 inhibitor TTI-101 in patients with advanced cancers has completed, with enrollment across multiple tumor typ…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer [Phase 2]
Phase 2 trial update evaluating fruquintinib in combination with a PD-1 inhibitor as first-line maintenance therapy for advanced gastric can…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01) [NA]
This clinical trial update describes SPACE-01, a study evaluating single- or reduced-port laparoscopic gastrectomy for advanced gastric canc…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer
This clinical trial update describes a study evaluating robotic-assisted surgery with Vessel Sealer Extend for locally advanced gastric canc…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating SL-279252, a PD-1-Fc-OX40L fusion protein, in adults with advanced solid tumors or lymphomas has been completed wit…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial [Phase 2]
Phase 2 trial (NCT04510064) evaluated camrelizumab combined with nab-POF chemotherapy in patients with initially unresectable locally advanc…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer [Phase 1, Phase 2]
A clinical trial update describes a planned first-line treatment for advanced gastric cancer using Fruquintinib in combination with a PD-1 i…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors [Phase 2]
Phase 2 trial of ladiratuzumab vedotin in multiple advanced solid tumors was terminated, with results posted in March 2025.
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients [Phase 1]
Phase 1 clinical trial evaluating CT041 as postoperative adjuvant therapy for gastric and gastroesophageal junction adenocarcinoma; the stud…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. [Phase 3]
Phase 3 trial update comparing zolbetuximab plus chemotherapy versus placebo plus chemotherapy in adults with gastric and gastroesophageal j…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology [Phase 2]
This document reports the completion of a Phase 2 trial evaluating heated intraperitoneal chemotherapy plus gastrectomy for gastric cancer w…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery
A longitudinal biomarker study in patients undergoing esophageal/gastric cancer surgery. Imperial College London is recruiting to profile bi…
-
CLINICAL_TRIALS withdrawal · 2025-02-07Clinical Trial Update: Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers [Phase 1]
A Phase 1 neoadjuvant therapy trial for gastroesophageal junction and gastric cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-06Clinical Trial Update: Molecular Analysis of Gastric and OEsophageal Cancers STudy
A molecular analysis study of gastric and esophageal cancers has been withdrawn from clinical trials.
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer
A clinical trial is evaluating different cycles of neoadjuvant PD-1 blockade plus chemotherapy for advanced gastric adenocarcinoma; recruitm…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW). [Phase 3]
A phase 3 trial (GLOW) evaluating zolbetuximab plus CAPOX versus placebo plus CAPOX in CLDN18.2-positive, HER2-negative gastric/GEJ adenocar…